NO20090470L - Farmasoytisk preparat omfattende en kombinasjon av piperidinalkanol og dekongestant - Google Patents

Farmasoytisk preparat omfattende en kombinasjon av piperidinalkanol og dekongestant

Info

Publication number
NO20090470L
NO20090470L NO20090470A NO20090470A NO20090470L NO 20090470 L NO20090470 L NO 20090470L NO 20090470 A NO20090470 A NO 20090470A NO 20090470 A NO20090470 A NO 20090470A NO 20090470 L NO20090470 L NO 20090470L
Authority
NO
Norway
Prior art keywords
therapeutic agent
decongestant
pharmaceutical composition
combination
alkanol
Prior art date
Application number
NO20090470A
Other languages
English (en)
Norwegian (no)
Inventor
Limor Ari-Pardo
Sivan Antler
Rina Zilberman
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of NO20090470L publication Critical patent/NO20090470L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A61K9/2081—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets with microcapsules or coated microparticles according to A61K9/50
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
NO20090470A 2006-06-30 2009-01-29 Farmasoytisk preparat omfattende en kombinasjon av piperidinalkanol og dekongestant NO20090470L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81741106P 2006-06-30 2006-06-30
PCT/US2007/015038 WO2008005287A1 (en) 2006-06-30 2007-06-28 Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant

Publications (1)

Publication Number Publication Date
NO20090470L true NO20090470L (no) 2009-01-29

Family

ID=38669916

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20090470A NO20090470L (no) 2006-06-30 2009-01-29 Farmasoytisk preparat omfattende en kombinasjon av piperidinalkanol og dekongestant

Country Status (12)

Country Link
US (1) US20080118554A1 (ja)
EP (1) EP2046303A1 (ja)
JP (1) JP2009542669A (ja)
KR (1) KR20090016612A (ja)
CN (1) CN101478958A (ja)
BR (1) BRPI0712960A2 (ja)
CA (1) CA2654525A1 (ja)
IL (1) IL195726A0 (ja)
MX (1) MX2008016565A (ja)
NO (1) NO20090470L (ja)
RU (1) RU2008150430A (ja)
WO (1) WO2008005287A1 (ja)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070253927A1 (en) * 2006-04-13 2007-11-01 Gwenaelle Jegou Cosmetic compositions comprising at least one dielectrophile monomer and at least one radical initiator
RU2009106681A (ru) * 2006-07-28 2010-09-10 Др.Редди`С Лабораторис Лтд. (In) Гранулированные фармацевтические композиции
WO2008114280A1 (en) * 2007-03-21 2008-09-25 Lupin Limited Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine
CN104232617A (zh) * 2008-05-23 2014-12-24 生命科技公司 用于dna提取的方法和试剂盒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0811374A1 (en) * 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
CN1158071C (zh) * 1997-05-30 2004-07-21 渗透有限公司 多层渗透装置
KR100514264B1 (ko) * 1997-08-26 2005-09-15 아벤티스 파마슈티칼스 인크. 피페리디노알칸올-충혈완화제 조합용 제약 조성물
ATE253354T1 (de) * 1999-02-23 2003-11-15 Yuhan Corp Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
WO2008005287A1 (en) 2008-01-10
KR20090016612A (ko) 2009-02-16
CA2654525A1 (en) 2008-01-10
MX2008016565A (es) 2009-01-19
CN101478958A (zh) 2009-07-08
EP2046303A1 (en) 2009-04-15
RU2008150430A (ru) 2010-08-10
US20080118554A1 (en) 2008-05-22
WO2008005287A8 (en) 2009-01-08
BRPI0712960A2 (pt) 2012-04-17
IL195726A0 (en) 2009-09-01
JP2009542669A (ja) 2009-12-03

Similar Documents

Publication Publication Date Title
ATE378042T1 (de) Arzneiimittel mit verdecktem geschmack in aufbrechenden multipartikeln
NO20090968L (no) Fremgangsmater for a behandle multippel myeloma ved anvendelse av kombinasjonsterapier basert pa anti-CS1 antistoffer
DOP2017000177A (es) Nuevos anticuerpos anti-cd38 para el tratamiento del cáncer
MX2021001957A (es) Compuestos de degradacion y metodos de uso del receptor de tropomiosina quinasa (trk).
NO20076613L (no) Farmasoytiske formuleringer og anvendelse derav
DOP2005000108A (es) Method for treating lupus
CL2007003429A1 (es) Tableta bi-capa que comprende una primera capa con al menos un estrogeno y una segunda capa con uno o mas agentes terapeuticos seleccionados entre un modulador selectivo del receptor de estrogeno y un agente progestacional; proceso de produccion, uti
AR058126A1 (es) Antagonistas y conjugados del peptido cgrp
AR054094A1 (es) Tratamientos de cancer
NO20074999L (no) Metode og preparat for behandling av perifere vaskulaere sykdommer
CL2021002651A1 (es) Métodos de tratamiento del linfoma no hodgkin usando 2- (2,6-dioxopiperidin-3-yl) -4 - ((2-fluoro-4 - ((3-morfolinoazetidin-1-yl) metil) bencil) amino) isoindolina- 1,3-diona
AR053026A1 (es) Composiciones de anticuerpos anti factor de estimulacion de colonias de macrofagos (anti-m csf)
WO2005070462A3 (en) Compositions comprising (s)-amlodipine and an angiotensin receptor blocker and methods of their use
WO2005084296A3 (en) Fused tricyclic compounds as inhibitors of 17beta-hydroxysteroid dehydrogernase 3
NO20091734L (no) Glucagonreseptorantagonistforbindelser, preparater inneholdende slike forbindelser, og metoder for anvendelse
WO2009083544A3 (en) Pdgf fusion proteins incorporated into fibrin foams
ATE521339T1 (de) Pharmazeutische zusammensetzung aus venlafaxin- hydrochlorid mit kontrollierter freisetzung und herstellungsverfahren dafür
NO20090470L (no) Farmasoytisk preparat omfattende en kombinasjon av piperidinalkanol og dekongestant
WO2009032057A3 (en) Method for the selective therapy of disease
DK2012764T3 (da) Farmaceutisk kombination omfattende 3-(3-dimethylamino-1-ethyl-2methyl-propyl)-phenol og paracetamol
MXPA05004697A (es) Soluciones farmaceuticas que comprenden un compuesto modafinil y uso para la fabricacion de un medicamento para tratar diferentes enfermedades.
ATE540710T1 (de) Arzneimittel freisetzendes medizinprodukt und verfahren
CY1112269T1 (el) Συνθεσεις και μεθοδοι για την αγωγη, μειωση, βελτιωση, ή ανακουφιση των οφθαλμικων παθησεων οπισθιου- τμηματος
DE60313296D1 (de) Pharmazeutische darreichungsformen, welche einen tablettenkern mit einer bruchfestigkeit unter 38n/qcm und einen überzug zum schutz des weichen kerns enthalten
AR065342A1 (es) Composiciones farmaceuticas que contienen fumarato de quetiapina

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application